Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Allogeneic faecal microbiota, pooled

EU orphan designation number: EU/3/18/2083   
Active ingredient: Allogeneic faecal microbiota, pooled
Indication: Treatment of graft-versus-host disease
Sponsor: MaaT PHARMA
317 Avenue Jean Jaurès, 69007 Lyon, France

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2018 Orphan designation EMA/OD/123/18 (2018)7792 of 19/11/2018